Dieser Bericht wurde in Übereinstimmung mit den GRI-Standards: Option „Kern“ erstellt. Die GRI-Verweise sind im Fließtext gesetzt und dieser GRI-Inhaltsindex bietet eine Übersicht zu den relevanten Inhalten (der Index ist nur in englischer Sprache verfügbar).
GRI Index
GRI Standard | Indicator | Comment | Reference |
---|---|---|---|
Organizational Profile | |||
102-1 | Name of the organization | Imprint | |
102-2 | Activities, brands, products, and services | Group Management Report Business Segments |
|
102-3 | Location of headquarters | Imprint The Group's Business Model Notes |
|
102-4 | Location of operations | CEO Letter Group Management Report Business Segments Our value chain |
|
102-5 | Ownership and legal form | Group Management Report | |
102-6 | Markets served | Group Management Report Business Segments |
|
102-7 | Scale of the organization | Balance sheet Business Segments |
|
102-8 | Information on employees and other workers | d. No significant portion of our Group activities are performed by workers who are not employees. f. The data are compiled with the help of employee reporting tools of our business segments and agregated on the Group level. |
Strategy and management Exchange with employee representatives Fresenius Helios Evaluation |
102-9 | Supply chain | Our value chain Supply Chain |
|
102-10 | Significant changes to the organization and its supply chain | CEO Letter Business Segments |
|
102-11 | Precautionary Principle or approach | Opportunities and Risk Report Strategy and management Sustainability risks |
|
102-12 | External initiatives | Our work in associations and initiatives | |
102-13 | Membership of associations | Our work in associations and initiatives Transparency in the health care sector |
|
Strategy | |||
102-14 | Statement from senior decision-maker | CEO Letter Foreword |
|
102-15 | Key impacts, risks, and opportunities | Opportunities and Risk Report Sustainability risks Fresenius Helios Evaluation Fresenius Kabi Evaluation |
|
Ethics and Integrity | |||
102-16 | Values, principles, standards, and norms of behavior | CEO Letter Strategy and management Guidelines and regulations Foreword Code of Conduct |
|
102-17 | Mechanisms for advice and concerns about ethics | Our approach Guidelines and regulations Employee participation Comprehensive stakeholder dialog Evaluation |
|
Corporate Governance | |||
102-18 | Governance structure | Corporate Governance Declaration pg. 220 et seq. The Group Sustainability Board |
|
102-19 | Delegating authority | Our sustainability organization | |
102-20 | Executive-level responsibility for economic, environmental, and social topics | Our sustainability organization | |
102-21 | Consulting stakeholders on economic, environmental, and social topics | The Group Sustainability Board Comprehensive stakeholder dialog Employee participation |
|
102-22 | Composition of the highest governance body and its committees | Report of the Supervisory Board The Group Sustainability Board |
|
102-23 | Chair of the highest governance body | Report of the Supervisory Board The Group Sustainability Board |
|
102-24 | Nominating and selecting the highest governance body | Corporate Governance Declaration pg. 220 et seq. The Group Sustainability Board |
|
102-25 | Conflicts of interest | Supervisory Board (Corporate Governance) Guidelines and regulations Dealing with conflicts of interest |
|
102-26 | Role of highest governance body in setting purpose, values, and strategy | Our sustainability organization The Group Sustainability Board |
|
102-27 | Collective knowledge of highest governance body | Our sustainability organization | |
102-28 | Evaluating the highest governance body’s performance | Compensation Report pg. 234 et seq. The business model Our sustainability goals and programs |
|
102-29 | Identifying and managing economic, environmental, and social impacts | The Group Sustainability Board | |
102-30 | Effectiveness of risk management processes | Our sustainability organization | |
102-31 | Review of economic, environmental, and social topics | Our sustainability organization | |
102-32 | Highest governance body’s role in sustainability reporting | Report of the Supervisory Board Our sustainability organization Determination of the contents of the report |
|
102-33 | Communicating critical concerns | Our sustainability organization | |
102-35 | Remuneration policies | Our sustainability goals and programs | |
102-36 | Process for determining remuneration | Our sustainability goals and programs | |
102-37 | Stakeholders’ involvement in remuneration | Supervisory Board (Corporate Governance) Voting results of the Annual General Meeting 2021 |
|
Stakeholder Engagement | |||
102-40 | List of stakeholder groups | Stakeholder and partnerships | |
102-41 | Collective bargaining agreements | Exchange with employee representatives Our approach |
|
102-42 | Identifying and selecting stakeholders | Our materiality analysis Stakeholder and partnerships |
|
102-43 | Approach to stakeholder engagement | Our materiality analysis Comprehensive stakeholder dialog Transparency in the health care sector |
|
102-44 | Key topics and concerns raised | Our materiality process | |
Reporting Practice | |||
102-45 | Entities included in the consolidated financial statements | Notes Report framework |
|
102-46 | Defining report content and topic Boundaries | Material analysis results Determination of the contents of the report |
|
102-47 | List of material topics | Our materiality analysis | |
102-48 | Restatements of information | If any restatement was conducted, the company explicitly states and explains the restatement. | Waste and recycling management (Footnote Evaluation) Water management (Footnote Evaluation) Climate protection - energy and emissions (Footnote Evaluation) |
102-49 | Changes in reporting | No significant changes on key topics and topic boundaries must be given with regard to the previous reporting periods. | |
102-50 | Reporting period | Report profile | |
102-51 | Date of most recent report | Our most recent combined annual and non-financial report 2021 was published on 24.03.2022. | |
102-52 | Reporting cycle | Due to German Commercial Law, Fresenius applies a yearly reporting cycle. | |
102-53 | Contact point for questions regarding the report | Report profile | |
102-54 | Claims of reporting in accordance with the GRI Standards | Report profile | |
102-55 | GRI content index | GRI Index | |
102-56 | External assurance | External audit |
GRI Standard | Indicator | Comment | Reference |
---|---|---|---|
GRI 201: Economic Performance 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Group Management Report Economic Report Strategy and management |
|
103-2 | The management approach and its components | Group Management Report Economic Report Strategy and management |
|
103-3 | Evaluation of the management approach | Group Management Report Economic Report Strategy and management |
|
201-2 | Financial implications and other risks and opportunities due to climate change | Sustainability risks EU taxonomy Comprehensive stakeholder dialog |
|
201-4 | Financial assistance received from government | Notes pg. 312 et seq. | |
GRI 204: Procurement Practices 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Supply Chain Access to health care and medicine |
|
103-2 | The management approach and its components | Supply Chain Access to health care and medicine Health care delivery during the COVID-19 pandemic |
|
103-3 | Evaluation of the management approach | Supplier evaluation Health care delivery during the COVID-19 pandemic |
|
204-1 | Proportion of spending on local suppliers | We take human rights concerns into account when selecting and cooperation with suppliers. As of now, we do not collect data on the proportion of spending on local suppliers. We are working to increase the transparency of our supply chains and build up our data management. | |
GRI 205: Anti-Corruption 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Our approach |
|
103-2 | The management approach and its components | Our approach Tax compliance |
|
103-3 | Evaluation of the management approach | Evaluation | |
205-2 | Communication and training about anti-corruption policies and procedures | Data is currently not available on a comparable reporting level for the segments of the Fresenius Group. We are working on improving the standardization of quantitative data and seek to expand the reporting going forward. | Compliance training |
205-3 | Confirmed incidents of corruption and actions taken | Due to confidentiality constraints, we do not disclose these figures in more detail. | Reports in 2021 |
GRI 207: Tax 2019 | |||
103-1 | Explanation of the material topic and its Boundary | Tax compliance | |
103-2 | The management approach and its components | Tax compliance | |
103-3 | Evaluation of the management approach | ||
207-1 | Approach to tax | Tax compliance | |
207-2 | Tax governance, control, and risk management | Tax compliance | |
207-4 | Country-by-country reporting | Tax compliance |
GRI Standard | Indicator | Comment | Reference |
---|---|---|---|
GRI 302: Energy 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Energy and emissions | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
302-1 | Energy consumption within the organization | Evaluation | |
302-2 | Energy consumption outside of the organization | We are currently building up our data collection in the course of our climate strategy. Not all information is available on a comparable reporting level for Fresenius Group yet. We seek to collect Scope 3 emissions data and expand the reporting going forward. | Our sustainability goals and programs |
302-3 | Energy intensity | Evaluation | |
GRI 303: Water and Effluents 2018 | |||
103-1 | Explanation of the material topic and its Boundary | Water management | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation Water withdrawal per hospital bed |
|
303-1 | Interactions with water as a shared resource | Evaluation | |
303-2 | Management of water discharge-related impacts | Fresenius Kabi Water management Fresenius Kabi Access to health care and medicine |
|
303-3 | Water withdrawal | For the health and safety of our patients, the management of water supply is most relevant. We have installed risk-based testing processes at all hospitals and health-care facilities to detect contamination or deviations in drinking water quality. In Germany, some of our hospitals are designated as testing centers for local drinking water quality. | Evaluation |
303-4 | Water discharge | Progress and measures in 2021 Fresenius Kabi |
|
GRI 305: Emissions 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Energy and emissions | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
305-1 | Direct (Scope 1) GHG emissions | Fresenius Group calculates its GHG emissions in tCO2 equivalents, thereby including all relevant greenhouse gases. The calculation for gross tCO2e, broken down into the business segments, was first conducted in 2017 and updated in 2020, which also serves as the base year for the climate target. Our consolidation approach is the same as in our financial reporting. The calculation was based on the methodology of the Greenhouse Gas Protocol and the latest versions of IEA and DEFRA emission factors. | Evaluation |
305-2 | Energy indirect (Scope 2) GHG | Data cannot yet be provided in more detail, e.g. split by market- based Scope 2 emissions, on a Group level. We are working on further refining the data collection process and providing more insights into our Scope 2 GHG emissions. | Evaluation |
305-3 | Other indirect (Scope 3) GHG emissions | We are currently working on collecting Scope 3 emissions data and aim to report on them in more detail going forward. | Our ambitions |
305-4 | GHG emissions intensity | Evaluation | |
305-5 | Reduction of GHG emissions | We are currently building up our data collection in the course of our climate strategy. Not all information is available on a comparable reporting level for Fresenius Group yet. We seek to expand the reporting going forward. | Evaluation |
GRI 306: Waste 2020 (updated) | |||
103-1 | Explanation of the material topic and its Boundary | Waste and recycling management | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
306-1 | Waste generation and significant waste-related impacts | Our approach | |
306-3 | Waste generated | Evaluation |
GRI Standard | Indicator | Comment | Reference |
---|---|---|---|
GRI 401: Employment 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Working conditions, recruitment and employee participation | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
401-1 | New employee hires and employee turnover | Fresenius currently only discloses the voluntary turnover rate by business segment and for Fresenius Group. Intersegment hires are counted as external hires by the business segments, while from a Group perspective it would be an internal hire. Therefore, we will not provide a consolidated Group figure.Breakdowns into age group and gender are only available for selected business segments due to system limitations. Therefore, consolidation on the Group level is not possible. | Evaluation |
401-2 | Benefits provided to full-time employees that are not provided to temporary or part-time employees | Working conditions | |
401-3 | Parental leave | Figures are disclosed for Germany. Regulatory provisions for parental leave vary from region to region. We focus on Germany in our reporting and assess to expand the reporting to further countries going forward. | Evaluation |
GRI 403: Occupational Health and Safety 2018 | |||
103-1 | Explanation of the material topic and its Boundary | Occupational health and safety | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Fresenius Medical Care Evaluation Fresenius Kabi Evaluation Fresenius Helios Evaluation Fresenius Vamed Evaluation |
|
403-1 | Occupational health and safety management system | All business segments have implemented OHS management systems according to their respective business models and take into account all relevant legal requirements. Fresenius Medical Care, Fresenius Kabi and Fresenius Helios use OHS systems in accordance with ISO 45001. We are continuously working on driving coverage forward. | Certifications and commitment |
403-2 | Hazard identification, risk assessment, and incident investigation | Our approach Reporting systems Fresenius Medical Care Evaluation Fresenius Kabi Evaluation Fresenius Helios Evaluation Fresenius Vamed Evaluation |
|
403-3 | Occupational health services | Our approach Promotion of good health in the business segments |
|
403-4 | Worker participation, consultation, and communication on occupational health and safety | Reporting systems | |
403-5 | Worker training on occupational health and safety | Training | |
403-6 | Promotion of worker health | Promotion of good health in the business segments | |
403-7 | Prevention and mitigation of occupational health and safety impacts directly linked by business relationships | Training | |
403-8 | Workers covered by an occupational health and safety management system | Certifications and commitment | |
403-9 | Work-related injuries | Fresenius Medical Care Fresenius Kabi Fresenius Helios Fresenius Vamed |
|
403-10 | Work-related ill health | Fresenius Medical Care Evaluation Fresenius Kabi Evaluation Fresenius Helios Evaluation Fresenius Vamed Evaluation |
|
GRI 404: Training and Education 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Employee development | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
404-1 | Average hours of training per year per employee | The information available is not of sufficient and comparable quality on a group level, since training data is currently collected on the business segment level. We are working on improving standardization of data management and colllection across the Group. | Evaluation |
GRI 405: Diversity and Equal Opportunity 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Diversity and equal opportunities Human Rights Preventing discrimination and promoting equal opportunities |
|
103-2 | The management approach and its components | Our approach Dealing with incidents of discrimination |
|
103-3 | Evaluation of the management approach | Ambitions Evaluation |
|
405-1 | Diversity of governance bodies and employees | Not all information is available on a comparable reporting level for Fresenius Group. We are working on improving the standardization of relevant diversity categories and seek to expand the reporting going forward. | Corporate Governance Declaration pg. 220 Evaluation Diversity lived in the business segments Employees with disabilities Our ambitions Evaluation |
GRI 406: Non-Discrimination 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Diversity and equal opportunities Human Rights Guidelines and regulations |
|
103-2 | The management approach and its components | Our approach Dealing with incidents of discrimination Diversity lived in the business segments Reporting channels |
|
103-3 | Evaluation of the management approach | Evaluation | |
406-1 | Incidents of discrimination and corrective actions taken | Next to reporting systems for compliance reports on a Group level, some business segments have established additional reporting channels. Figures on reports of discrimination incidents received via Helios Spain's own reporting channel are disclosed for 2021. Fresenius Group will assess to broaden the reporting scope in the future. | Evaluation Fresenius Helios Evaluation |
GRI 407: Freedom of Association and Collective Bargaining 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Working conditions, recruitment and employee participation Human Rights |
|
103-2 | The management approach and its components | Our approach Exchange with employee representatives Our approach Respect the right to freedom of association and collective agreements Risk management and assessment Human rights training |
|
103-3 | Evaluation of the management approach | Exchange with employee representatives Dialog at European level Evaluation |
|
407-1 | Operations and suppliers in which the right to freedom of association and collective bargaining may be at risk | Risk management and assessment | |
GRI 408: Child Labor 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Human Rights | |
103-2 | The management approach and its components | Prohibiting exploitative and illegal child labor or forced labor Risk management and assessment Human rights training Guidelines and regulations |
|
103-3 | Evaluation of the management approach | Risk management and assessment Human rights training Evaluation |
|
408-1 | Operations and suppliers at significant risk for incidents of child labor | Data is currently not available on a comparable reporting level for Fresenius Group. We are working on improving the standardization of quantitative data and seek to expand the reporting going forward. | |
GRI 409: Forced or Compulsory Labor 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Human Rights Supply Chain |
|
103-2 | The management approach and its components | Prohibiting exploitative and illegal child labor or forced labor Human rights training Guidelines and regulations |
|
103-3 | Evaluation of the management approach | Risk management and assessment Human rights training |
|
409-1 | Operations and suppliers at significant risk for incidents of forced or compulsory labor | Data is currently not available on a comparable reporting level for Fresenius Group. We are working on improving the standardization of quantitative data and seek to expand the reporting going forward. | |
GRI 412: Human Rights Assessment 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Human Rights | |
103-2 | The management approach and its components | Our approach Risk management and assessment |
|
103-3 | Evaluation of the management approach | Evaluation | |
412-2 | Employee training on human rights policies or procedures | Human rights training | |
GRI 414: Supplier Social Assessment 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Supply Chain | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Supplier evaluation | |
414-2 | Negative social impacts in the supply chain and actions taken | Not all information is available of sufficient and comparable quality on a group level, since audit data is currently collected on the business segment level only. As part of our efforts to increase transparency in our supply chains, we are working on improving standardization of data management and colllection across the Group. | Supplier evaluation |
GRI 416: Customer Health and Safety 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Patient and product safety | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
416-1 | Assessment of the health and safety impacts of product and service categories | Certifications and commitment | |
416-2 | Incidents of non-Compliance concerning the health and safety impacts of products and services | Fresenius Medical Care Evaluation Fresenius Kabi Evaluation Fresenius Helios Evaluation Fresenius Vamed Evaluation |
|
GRI 417: Marketing and Labeling 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Patient and product safety | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
417-1 | Requirements for product and service information and labeling | Fresenius Medical Care Patient information Fresenius Kabi Labeling and product information Fresenius Helios Patient information Fresenius Vamed Patient information Evaluation |
|
GRI 418: Customer Privacy 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Cybersecurity Data Protection Transparency in the health care sector |
|
103-2 | The management approach and its components | Cybersecurity Data Protection |
|
103-3 | Evaluation of the management approach | Evaluation Audits and monitoring |
|
418-1 | Substantiated complaints concerning breaches of customer privacy and losses of customer data | We are diligently working to further mature our KPI reporting system for the Fresenius Group. Therefore, we are currently building up our data management and work on the defintion and reporting of KPIs on customer privacy, along with substantiated classification by severity. In the meantime, we abstain from reporting any KPIs externally to comply with our risk prevention acitivities. | Reports in 2021 |
GRI 419: Socioeconomic Compliance 2016 | |||
103-1 | Explanation of the material topic and its Boundary | Compliance | |
103-2 | The management approach and its components | Our approach | |
103-3 | Evaluation of the management approach | Evaluation | |
419-1 | Non-Compliance with laws and regulations in the social and economic area | Risks from litigation and legal proceedings are reported in our opportunities and risks report. Legal matters that the Fresenius Group currently deems to be material or noteworthy are described in the Notes of our Annual Report. | Opportunities and risks Notes |